Virios Therapeutics, LLC logo
Virios Therapeutics, LLC VIRI

Annual report 2025
added 03-18-2026

report update icon

Virios Therapeutics, LLC Total Current Liabilities 2011-2026 | VIRI

Annual Total Current Liabilities Virios Therapeutics, LLC

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.06 M 3.18 M 359 K 1.04 M 1.28 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.18 M 359 K 1.78 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
395 M $ 22.56 2.13 % $ 3.74 B usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
163 M $ 1.43 3.62 % $ 368 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
1.47 B $ 327.25 2.42 % $ 42.9 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.66 3.5 % $ 16.7 M usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
CymaBay Therapeutics CymaBay Therapeutics
CBAY
36.8 M - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
158 M $ 20.4 -0.87 % $ 954 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
47.6 M $ 4.18 1.21 % $ 447 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
70.6 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
49.6 M - - $ 1.41 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
130 M $ 24.61 5.76 % $ 3.13 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.2 M $ 3.09 0.65 % $ 310 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
16.1 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.49 9.56 % $ 397 M britainBritain
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
81.1 M - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1.33 M - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
100 M - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
Forte Biosciences Forte Biosciences
FBRX
20.8 M $ 26.27 0.38 % $ 340 M usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
12.4 M $ 3.88 2.11 % $ 261 B britainBritain
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA